Pseudoephedrine became available for over-the-counter sale for the first time in 13 years on 20 May, after the ACT Party delivered on its election promise to undo the 2011 reclassification of the product as a prescription-only medicine. Jonathan Chilton-Towle looks at what pharmacies have experienced since then